LCMS Solutions Names Private Equity Executive as CEO

LCMS Solutions said Wednesday that it has named Dale L. Ziegler as CEO. Previously, Ziegler worked as a managing director with Carlisle Enterprises, a La Jolla, CA- based private equity investment firm. LCMS is a provider of clinical diagnostic information to doctors.


San Diego, California (PRWEB) July 17, 2013
LCMS Solutions Inc. is pleased to announce the appointment of Dale L. Ziegler as Chief Executive Officer. LCMS is a CLIA certified laboratory providing clinical diagnostic information to doctors, utilizing the latest mass spectrometry technology and techniques to support medical professionals and mitigate risk to patients.
“Dale brings decades of successful management experience to the team” said Dr. Mark Lortie, Chief Scientific Officer of LCMS, “we are excited to have him join our rapidly growing company.”
Prior to joining LCMS, Mr. Ziegler was a Managing Director with Carlisle Enterprises, LLC, a La Jolla, CA based private equity investment firm since 1993. Mr. Ziegler has extensive experience in problem-solving environments including business evaluation, planning and strategy formulation, crisis management and restructuring as well as streamlining operations. His background as a senior financial and operating executive provided him with vast expertise in operational controls, including profit improvement/cost reduction, cash flow management and asset management.
Mr. Ziegler previously served on the boards and was actively involved in the management of UVP, LLC, Contractors Wire & Cable, LLC, Benetech, Inc., Kendro Laboratory Products and Garrett Aviation Services, all of which are former Carlisle portfolio companies.
Said Ziegler “The advanced technology we employ and the reputation of the team were key factors in my decision to join LCMS Solutions. I’m enthusiastic about the opportunity to lead the organization at this exciting time in our growth.”
About LCMS Solutions
LCMS Solutions is a CLIA certified laboratory providing comprehensive toxicology and clinical testing services through the most accurate urine drug testing (UDT) available. Utilizing the latest mass spectrometry technology and techniques to provide fast, accurate information we also offer the distinct advantage of expert consultative services provided by two recognized authorities in this discipline. Our science supports the medical community by providing validation and information to mitigate risk to patients and practitioners.